rs34704118

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001378778.1(MPDZ):​c.2580A>G​(p.Leu860Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00582 in 1,612,418 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0040 ( 0 hom., cov: 32)
Exomes š‘“: 0.0060 ( 39 hom. )

Consequence

MPDZ
NM_001378778.1 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.108

Publications

7 publications found
Variant links:
Genes affected
MPDZ (HGNC:7208): (multiple PDZ domain crumbs cell polarity complex component) The protein encoded by this gene has multiple PDZ domains, which are hallmarks of protein-protein interactions. The encoded protein is known to interact with the HTR2C receptor and may cause it to clump at the cell surface. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
MPDZ Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 9-13183487-T-C is Benign according to our data. Variant chr9-13183487-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211510.
BP7
Synonymous conserved (PhyloP=-0.108 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00404 (614/152084) while in subpopulation NFE AF = 0.00629 (427/67928). AF 95% confidence interval is 0.00579. There are 0 homozygotes in GnomAd4. There are 284 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 39 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPDZNM_001378778.1 linkc.2580A>G p.Leu860Leu synonymous_variant Exon 19 of 47 ENST00000319217.12 NP_001365707.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPDZENST00000319217.12 linkc.2580A>G p.Leu860Leu synonymous_variant Exon 19 of 47 5 NM_001378778.1 ENSP00000320006.7

Frequencies

GnomAD3 genomes
AF:
0.00403
AC:
613
AN:
151966
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00126
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00467
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00629
Gnomad OTH
AF:
0.00671
GnomAD2 exomes
AF:
0.00440
AC:
1089
AN:
247636
AF XY:
0.00451
show subpopulations
Gnomad AFR exome
AF:
0.00110
Gnomad AMR exome
AF:
0.00309
Gnomad ASJ exome
AF:
0.00918
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000559
Gnomad NFE exome
AF:
0.00644
Gnomad OTH exome
AF:
0.00634
GnomAD4 exome
AF:
0.00600
AC:
8767
AN:
1460334
Hom.:
39
Cov.:
31
AF XY:
0.00594
AC XY:
4318
AN XY:
726430
show subpopulations
African (AFR)
AF:
0.000928
AC:
31
AN:
33416
American (AMR)
AF:
0.00350
AC:
156
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.00851
AC:
222
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39544
South Asian (SAS)
AF:
0.00354
AC:
305
AN:
86176
European-Finnish (FIN)
AF:
0.000769
AC:
41
AN:
53348
Middle Eastern (MID)
AF:
0.0111
AC:
64
AN:
5758
European-Non Finnish (NFE)
AF:
0.00680
AC:
7556
AN:
1111146
Other (OTH)
AF:
0.00650
AC:
392
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
443
886
1330
1773
2216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00404
AC:
614
AN:
152084
Hom.:
0
Cov.:
32
AF XY:
0.00382
AC XY:
284
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.00125
AC:
52
AN:
41544
American (AMR)
AF:
0.00466
AC:
71
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.00894
AC:
31
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4820
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00629
AC:
427
AN:
67928
Other (OTH)
AF:
0.00664
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00470
Hom.:
1
Bravo
AF:
0.00487
Asia WGS
AF:
0.00144
AC:
5
AN:
3476
EpiCase
AF:
0.00873
EpiControl
AF:
0.00667

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MPDZ: BP4, BP7 -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jan 29, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MPDZ-related disorder Benign:1
Sep 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
2.2
DANN
Benign
0.80
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34704118; hg19: chr9-13183486; API